| Immune/inflammatory factors | Type | Effect of GL/GA | Citations |
| Inflammation | VEGF | Inhibitory | [40] | | ICAM-1 | Inhibitory | [40] | | GM-CSF | Inhibitory | [40] | | GRO/KC | Inhibitory | [40] | | PLA2/ARA | Inhibitory | [36, 41, 42] | | MMP-9 | Inhibitory | [41, 43] | | STAT-3 | Inhibitory | [45–47] | | STAT-6 | Inhibitory | [45–47] | | pADR | Inhibitory | [45–47] | | NTS | Inhibitory | [45–47] | | PMN | Inhibitory | [45–47] | | SOD | Facilitatory | [41, 44] | | GSH-Px | Facilitatory | [41, 44] | | TGF-β | Facilitatory | [25] | Dendritic cells (DCs) | T-cell | Facilitatory | [4] | | Th1 | Facilitatory | [4] | | Th2 | Facilitatory | [25] | Nuclear factor-κB | — | Inhibitory | [6, 20, 62–65] | | IKK | Inhibitory | [56] | Chemokines | CXCL10 | Inhibitory | [20, 30, 70, 71] | | CCL5 | Inhibitory | [20, 30, 70, 71] | | CCL11 | Inhibitory | [39, 76–78] | Interferons | IFN-γ | Facilitatory | [85–89] | Cyclooxygenase | COX-1 | — | — | | COX-2 | Inhibitory | [25, 65, 98] | Interleukins | IL-1 | Inhibitory | [8, 104–106] | | IL-2 | Facilitatory | [4, 9, 106] | | IL-3 | Inhibitory | [8, 104–106] | | IL-4 | Inhibitory | [8, 104–106] | | IL-5 | Inhibitory | [8, 104–106] | | IL-6 | Inhibitory | [8, 104–106] | | IL-10 | Inhibitory | [8, 104–106] | | IL-12 | Inhibitory | [4, 8, 104–106] | | IL-13 | Inhibitory | [8, 104–106] | | IL-18 | Inhibitory | [8, 104–106, 111] | Mitogen-activated protein kinase | — | Inhibitory | [6, 115, 116, 141] | | p38MAPK | Inhibitory | [6, 115, 116] | | ERK | Inhibitory | [45] | | JNK | Inhibitory | | Nitric oxide | iNOS | Inhibitory | [45] | | eNOS | — | — | | nNOS | — | — | Toll-like receptors | TLR-3 | Inhibitory | [131–134] | | TLR-4 | Inhibitory | [131–134, 141] | | TLR-7 | Inhibitory | [131–134] | | TLR-9 | Inhibitory | [131–134] | | TLR-10 | Inhibitory | [131–134] | High-mobility group box 1 | — | Inhibitory | [141, 142] |
|
|